This site is intended for healthcare professionals
Psoriasis Learning Zone

COVID-19 in Context

Read time: 30 mins
Last updated:29th May 2020
Published:29th May 2020
Despite ongoing research efforts, COVID-19 is not yet fully understood. As such, there is limited information how this disease affects patients with psoriasis. This section examines how dermatologists around the world have adapted to the crisis, with information on current recommendations and the growing use of teledermatology.

The COVID-19 pandemic is now regarded as a global health crisis, but despite an ongoing international research effort, our understanding of the disease remains limited. 

This includes a lack of data regarding how the virus affects patients treated for immune-mediated inflammatory diseases like psoriasis (Schett et al., 2020).

Register free for full access to medthority.com

Around the world, medical professionals have been forced to adopt new approaches to patient care in response to the COVID-19 pandemic. 

Amid the crisis, telemedicine has emerged as an effective means of providing certain patients with continued access to healthcare services while minimising risk of viral transmission (Smith et al., 2020).

Register free for full access to medthority.com

The psychological impact of COVID-19 on patients with psoriasis

For many people around the world, enforced social isolation, increased health anxiety, media misinformation, and fears regarding the potential socio-economic impact of the COVID-19 pandemic have contributed to a considerable decline in psychological wellbeing (Rajkumar, 2020).

Register free for full access to medthority.com

Also available in German

The Psoriasis Learning Zone is also translated and available in German.

Welcome:

Developed by EPG Health for Medthority Supported by an educational grant from Janssen.